Department of Pediatrics, University Hospital of North Norway, N 9038, Tromsø, Norway.
Ann Rheum Dis. 2012 Jul;71(7):1122-7. doi: 10.1136/annrheumdis-2011-200237. Epub 2012 Jan 17.
To compare the juvenile arthritis disease activity score (JADAS) based on C reactive protein (CRP) (JADAS-CRP) with JADAS based on erythrocyte sedimentation rate (ESR) (JADAS-ESR) and to validate JADAS in a population-based setting.
The CRP and ESR values and the corresponding JADAS scores (JADAS10/27/71) were compared in a longitudinal cohort study of 389 children newly diagnosed with juvenile idiopathic arthritis (JIA) in the Nordic JIA study. The construct validity and the discriminative and predictive ability of JADAS were assessed during a median disease course of 8 years by comparing JADAS with other measures of disease activity and outcome.
At the first study visit the correlation between JADAS27-CRP and JADAS27-ESR was r=0.99 whereas the correlation between CRP and ESR was r=0.57. Children with higher JADAS scores had an increased risk of concomitant pain, physical disability and use of disease-modifying antirheumatic drugs (DMARDs). A higher JADAS score at the first study visit also significantly predicted physical disability, damage and no remission off medication at the final study visit, and also use of DMARDs during the disease course. Sensitivity to change, demonstrated as change in JADAS score compared with the American College of Rheumatology paediatric measures of improvement criteria, mostly showed excellent classification ability.
The JADAS-CRP and JADAS-ESR correlate closely, show similar test characteristics and are feasible and valid tools for assessing disease activity in JIA.
比较基于 C 反应蛋白(CRP)的幼年特发性关节炎疾病活动评分(JADAS-CRP)与基于红细胞沉降率(ESR)的 JADAS(JADAS-ESR),并在基于人群的环境中验证 JADAS。
在北欧幼年特发性关节炎研究中,对 389 例新诊断为幼年特发性关节炎(JIA)的儿童进行了纵向队列研究,比较了 CRP 和 ESR 值及其相应的 JADAS 评分(JADAS10/27/71)。通过比较 JADAS 与其他疾病活动和结局的衡量标准,评估了 JADAS 的结构有效性、判别和预测能力。
在首次研究访问时,JADAS27-CRP 和 JADAS27-ESR 之间的相关性为 r=0.99,而 CRP 和 ESR 之间的相关性为 r=0.57。JADAS 评分较高的儿童并发疼痛、身体残疾和使用疾病修饰抗风湿药物(DMARDs)的风险增加。首次研究访问时的 JADAS 评分较高也显著预测了最终研究访问时的身体残疾、损害和无药物缓解,以及疾病过程中使用 DMARDs。变化的敏感性,表现为与美国风湿病学会儿科改善标准衡量的 JADAS 评分变化相比,主要显示出极好的分类能力。
JADAS-CRP 和 JADAS-ESR 相关性密切,具有相似的测试特征,是评估 JIA 疾病活动的可行和有效工具。